loading...| Preferred Name |
Cisatracurium |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C77365 |
| CAS_Registry |
96946-41-7 |
| Chemical_Formula |
C53H72N2O12 |
| code |
C77365 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class, with skeletal muscle relaxing activity. Cisatracurium besylate acts as a competitive acetylcholine antagonist that binds to nicotinic receptors at the neuromuscular junction. This blocks neuromuscular transmission and causes neuromuscular relaxation. |
| FDA_UNII_Code |
QX62KLI41N |
| FULL_SYN |
Cisatracurium Isoquinolinium, 2,2'-(1,5-Pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2R,1'R,2'R)- CISATRACURIUM (1R,2R,1'R,2'R)-2,2'-(Pentane-1,5-diylbis(oxy(3-oxopropane-3,1-diyl)))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium) |
| Has_Salt_Form | |
| label |
Cisatracurium |
| Legacy Concept Name |
Cisatracurium |
| Preferred_Name |
Cisatracurium |
| prefixIRI |
Thesaurus:C77365 |
| prefLabel |
Cisatracurium |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C1096766 |
| subClassOf |